CVSA — COVISTA INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About COVISTA INC (CVSA)
COVISTA INC (CVSA) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $16M. Across recent filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in CVSA
How many top investors track CVSA
A small number of top investors own this.
CVSA Ownership Composition
How COVISTA INC is held across tracked investor types, based on reported 13F positions.
- Other99.0%
- Hedge Funds1.0%
Tracked investors reporting CVSA
- Izzy EnglanderMar 31, 2026Millennium ManagementShares82.4KValue$9.5M% Portfolio0.00%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares116.4KValue$13.4M% Portfolio0.00%
- Ray DalioMar 31, 2026Bridgewater AssociatesShares14.7KValue$1.7M% Portfolio0.01%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares2.2KValue$253.6K% Portfolio0.00%
Recent activity
- $16.1MFeb 17, 2026
- New$672.6KFeb 17, 2026
- New$253.6KMay 15, 2026
- New$1.7MMay 15, 2026
Frequently asked questions
- How many institutional investors hold CVSA?
- 4 tracked institutional investors disclosed a position in CVSA (COVISTA INC) in their most recent 13F filing.
- Who is the largest institutional holder of CVSA?
- Izzy Englander, Millennium Management, holds the largest disclosed position in CVSA, valued at $16M.
- Did institutional ownership of CVSA increase or decrease?
- Across recent 13F filings, tracked investors recorded 4 new positions, 0 increased, 0 reduced, and 0 fully exited CVSA.
- Where does this CVSA ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.